Milacemide

米拉醋胺

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameMilacemide
Drug Alias NameGlyzacGlyzanCP-1552-S
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMonoamine oxidase B inhibitorsGlutamate [NMDA] receptor agonists
TargetsMonoamine oxidase BGlutamate [NMDA] receptor
Therapy Area/IndicationsEpilepsyAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsEpilepsyAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG